[HTML][HTML] COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

P Demelo-Rodriguez, R Alonso-Beato… - Research and Practice …, 2023 - Elsevier
Background Complications under anticoagulant treatment in patients with COVID-19-
associated venous thromboembolism (VTE) have not been consistently reported. Objectives …

Demographic and clinical profile of patients suffering prolonged severe hypoxia in COVID-19

S Shah, D Valiani, O Balogun, MA Zanoria… - Expert Review of …, 2022 - Taylor & Francis
ABSTRACT Background Coronavirus disease 2019 (COVID-19) may result in rapid onset of
hypoxemic respiratory failure. This study aimed to characterize the factors and outcomes …

Incidence & outcomes of clinically significant bleeding events in critically ill COVID-19 patients receiving Therapeutic dose AntiCoagulanTs: A retrospective cohort …

A Singh, A Dhir, K Kajal, NB Naik… - Indian Journal of …, 2022 - journals.lww.com
Methods: In this retrospective, single-centre study of 155 critically ill COVID-19 patients, the
incidence of clinically significant bleeding was observed. Multivariate regression models …

Evaluasi Penggunaan Antikoagulan Profilaksis terhadap Pasien COVID-19

EDS Rante, E Nangoy, J Posangi - eBiomedik, 2022 - ejournal.unsrat.ac.id
Kejadian hiperinflamasi pada pasien COVID-19 mengakibatkan peningkatan aktivasi
kaskade koagulasi dan produksi trombin yang berlebihan. Koagulopati pada pasien dengan …

Thromboprophylaxis strategies for hospitalized patients with COVID-19

M Porres-Aguilar, D Mukherjee, A Lazo-Langner - Chest, 2022 - journal.chestnet.org
1. Zhang M, Fan Y, Nie L, et al. Clinical outcomes of immune checkpoint inhibitor therapy in
patients with advanced non-small cell lung cancer and preexisting interstitial lung diseases …

[HTML][HTML] Thromboprophylaxis in Patients With Cancer and COVID-19

R Lecumberri, M Marcos-Jubilar… - Archivos de …, 2022 - ncbi.nlm.nih.gov
Interest in thromboprophylaxis has increased since the onset of the SARS-CoV-2 pandemic.
It quickly became clear that patients hospitalized for COVID-19 should receive …

COVID-19 and Thrombosis: Pathophysiological Mechanisms and Therapeutic Update

I Izuzquiza-Avanzini, R Gutiérrez-López… - Anticoagulation …, 2022 - books.google.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pro-inflammatory and
prothrombogenic virus with a high mutagenic profile, which produces active infection of …

Status und Empfehlungen zur interventionell-radiologischen Versorgung bei COVID-19-PatientInnen

R Reimer, D Zopfs, E Celik, P Reimer - Die Radiologie, 2023 - Springer
Zusammenfassung Hintergrund Insbesondere zu Beginn führte die COVID-19-Pandemie
(„coronavirus disease 2019 “) zu einer Reduktion der Eingriffszahlen in der interventionellen …

[HTML][HTML] Hematoma retroperitoneal espontáneo en pacientes con neumonía grave por SARS-CoV-2

B Villota Tamayo, A Perfecto Valero… - Angiología, 2023 - SciELO Espana
Recientemente se han publicado varios casos de hematomas retroperitoneales
espontáneos (HRE) en el contexto de infección por SARS-CoV-2. Este estudio presenta una …

[PDF][PDF] Validation of a Prognostic Score to Identify Hospitalized Patients with COVID-19 at Increased Risk for Bleeding. Viruses 2021, 13, 2278

P Demelo-Rodriguez, F Galeano-Valle… - 2021 - academia.edu
Introduction: Hospitalized patients with COVID-19 are at increased risk for venous
thromboembolism (VTE), but also for bleeding. We previously derived a prognostic score …